Similar articles for PMID: 28254865

Year	Number of Results
1944	1
2009	3
2010	4
2011	2
2012	3
2013	2
2014	7
2015	8
2016	14
2017	20
2018	8
2019	3
2020	2
2021	1
2022	2
2023	1
2024	1
2025	0

1

Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer.

Jo J, Kwon HW, Park S, Oh DY, Cheon GJ, Bang YJ. Jo J, et al. J Nucl Med. 2017 Aug;58(8):1255-1261. doi: 10.2967/jnumed.116.186239. Epub 2017 Mar 2. J Nucl Med. 2017. PMID: 28254865 Free article. Clinical Trial.

2

Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.

Cho KM, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ. Cho KM, et al. Oncologist. 2015 Aug;20(8):926-33. doi: 10.1634/theoncologist.2014-0356. Epub 2015 Jun 22. Oncologist. 2015. PMID: 26099746 Free PMC article.

3

Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.

Park S, Ha S, Kwon HW, Kim WH, Kim TY, Oh DY, Cheon GJ, Bang YJ. Park S, et al. J Nucl Med. 2017 Jun;58(6):899-904. doi: 10.2967/jnumed.116.182675. Epub 2016 Nov 10. J Nucl Med. 2017. PMID: 28572288 Free article. Clinical Trial.

4

Prognostic and predictive value of metabolic tumor volume on (18)F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib.

Choi MK, Choi JY, Lee J, Heo JS, Choi SH, Choi DW, Lee KT, Lee JK, Lee KH, Park JO, Park YS, Lim HY. Choi MK, et al. Med Oncol. 2014 Jul;31(7):23. doi: 10.1007/s12032-014-0023-7. Epub 2014 Jun 10. Med Oncol. 2014. PMID: 24909509 Clinical Trial.

5

Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.

Braghiroli MI, Mota JM, Duarte PS, Morita TO, Bariani GM, Nebuloni D, Buchpiguel CA, Hoff PM, Riechelmann RP. Braghiroli MI, et al. Nucl Med Commun. 2018 Mar;39(3):252-259. doi: 10.1097/MNM.0000000000000810. Nucl Med Commun. 2018. PMID: 29381586 Clinical Trial.

6

Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.

Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D. Cacicedo J, et al. Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24. Clin Transl Oncol. 2017. PMID: 28540535

7

Measuring treatment response to systemic therapy and predicting outcome in biliary tract cancer: comparing tumor size, volume, density, and metabolism.

Sahani DV, Hayano K, Galluzzo A, Zhu AX. Sahani DV, et al. AJR Am J Roentgenol. 2015 Apr;204(4):776-81. doi: 10.2214/AJR.14.13223. AJR Am J Roentgenol. 2015. PMID: 25794066 Clinical Trial.

8

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.

Cho KM, Park H, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ. Cho KM, et al. Oncotarget. 2017 Jan 10;8(2):2329-2341. doi: 10.18632/oncotarget.13731. Oncotarget. 2017. PMID: 27911876 Free PMC article.

9

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.

Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H, Clark JW, Abrams TA, Chan JA, Enzinger PC, Bhargava P, Kwak EL, Allen JN, Jain SR, Stuart K, Horgan K, Sheehan S, Fuchs CS, Ryan DP, Sahani DV. Zhu AX, et al. Lancet Oncol. 2010 Jan;11(1):48-54. doi: 10.1016/S1470-2045(09)70333-X. Epub 2009 Nov 20. Lancet Oncol. 2010. PMID: 19932054 Clinical Trial.

10

Elevated tumor-to-liver uptake ratio (TLR) from ¹⁸F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.

Huang J, Huang L, Zhou J, Duan Y, Zhang Z, Wang X, Huang P, Tan S, Hu P, Wang J, Huang M. Huang J, et al. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1958-1968. doi: 10.1007/s00259-017-3779-0. Epub 2017 Aug 15. Eur J Nucl Med Mol Imaging. 2017. PMID: 28812134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 28254865

71 results

Results by year